JET-AVERT MOTION SICKNESS AID- meclizine hydrochloride tablet 
Bell Pharmaceuticals, Inc.

----------

Jet-Avert Motion Sickness Aid

Drug Facts

Active ingredient (in each tablet)

Meclizine HCL 25mg

Purpose

Antiemetic

Uses

Warnings

Do not use

  • for children under 12 years of age unless directed by a doctor

Ask a doctor  before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucome 
  • difficulty in urination due to enlargement prostate glad

Ask a doctor or pharmacist before useif you are taking

  • Sedatives • tranquilizers

When using this product

• drowsiness may occur • alcohol, sedatives, and tranquilizers may increase drowsiness • avoid alcoholic drinks • be careful when driving or operating machinery

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

 adults and children 12 years and over take 1 to 2 tablets once daily, or as directed by a doctor
 children under 12 years do not ues unless directed by doctor

Other information

Inactive ingredients

calcium stearate, FD&C red#40 aluminum lake, lactose, microcrystalline cellulose, silicon dioxide, sodium starch glycolate

Questions or comments?

1-800-328-5890 Weekdays 8:30-5:00 CST

Package Labeling:

Label

JET-AVERT MOTION SICKNESS AID 
meclizine hydrochloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:15579-837
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM STEARATE (UNII: 776XM7047L)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
LACTOSE (UNII: J2B2A4N98G)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorredScoreno score
ShapeROUNDSize4mm
FlavorImprint Code 25
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:15579-837-233 in 1 BOX10/07/2017
18 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00910/07/2017
Labeler - Bell Pharmaceuticals, Inc. (140653770)

Revised: 12/2023
Document Id: 0c86777f-3d08-5e1d-e063-6294a90a2369
Set id: 1fe1f806-cbf3-4308-8d70-201756e96cd1
Version: 2
Effective Time: 20231215
 
Bell Pharmaceuticals, Inc.